ELIANSH(SH:600836)2022-04-01 16:00Financial Performance - In 2021, the company's operating revenue was ¥833,088,414.25, a decrease of 62.02% compared to ¥2,193,293,041.73 in 2020[19] - The net profit attributable to shareholders was ¥206,706,065.54, down 12.00% from ¥234,904,818.54 in the previous year[19] - The net profit after deducting non-recurring gains and losses increased by 47.78% to ¥27,171,047.51 from ¥18,386,324.58 in 2020[19] - The company's total assets at the end of 2021 were ¥2,170,369,575.48, an increase of 8.60% from ¥1,998,461,410.19 at the end of 2020[19] - The net assets attributable to shareholders increased by 20.01% to ¥1,213,010,197.77 from ¥1,010,729,663.24 in 2020[19] - Basic earnings per share decreased by 11.86% to ¥0.312 from ¥0.354 in 2020[20] - The weighted average return on equity decreased by 7.76 percentage points to 18.57% from 26.33% in the previous year[20] - The company reported a net cash flow from operating activities of ¥189,172,479.77, a decrease of 19.30% from ¥234,408,165.78 in 2020[19] Business Operations - The company achieved a notable increase in its fast-moving consumer goods business, particularly in the eco-friendly paper bag segment, which is expected to drive revenue growth in 2022[26] - The company successfully completed the transfer of control in April 2021, leading to the removal of the delisting risk warning and a name change to "Shanghai Yilian" in June 2021[27] - The company is actively exploring acquisition targets in the pharmaceutical sector and has secured land for a new biopharmaceutical base, covering an area of 106,625 square meters[28] - The company received government subsidies totaling ¥202.6 million for high-tech projects, supporting its strategic transformation efforts[26] - The company has implemented refined management and technological innovations in its printing operations, resulting in improved production efficiency and quality[27] Revenue Breakdown - The main business revenue from the printing and packaging segment decreased by 23.15%, amounting to a reduction of 172.53 million yuan[34] - The company's real estate segment saw a significant revenue drop of 99.60%, leading to a profit reduction of 97.21 million yuan[35] - The printing and packaging segment increased profits by 22.76 million yuan, driven by new business expansion and adjustments to loss-making subsidiaries[38] - The commercial service sector saw a significant increase in revenue to CNY 205.09 million, with a gross margin of 76.08%, up 313.51% year-over-year[41] - The production of food and beverage packaging increased by 45.55% year-over-year, with sales up 32.42%[42] Strategic Initiatives - The company aims to diversify its operations while maintaining its competitive edge in the packaging printing industry[32] - The company is focusing on technological innovation in the printing sector, including the application of wide-format high-definition flexographic printing technology[33] - The company plans to accelerate its transformation by seeking potential acquisitions or partnerships within the industry to establish a diversified business model[79] - The company is committed to enhancing its operational management through standardization across various processes, including production and financial management[80] - The company aims to attract and cultivate high-caliber talent to support its new industry direction and enhance overall workforce efficiency[80] Corporate Governance - The company maintains a complete separation from its controlling shareholder in terms of personnel, assets, finance, and business operations, ensuring independent operation[86] - The company has established a complete marketing system across its subsidiaries, ensuring that business operations do not rely on the controlling shareholder[87] - The company has a dedicated human resources department responsible for employee assessment, training, and salary review, ensuring independent personnel management[87] - The company is actively engaging in stock incentive plans to align management interests with shareholder value[99] - The company is committed to transparency in reporting executive compensation and shareholding changes, reflecting good corporate governance practices[97] Shareholder Meetings - The company held its first extraordinary general meeting on February 3, 2021, with 180,837,180 shares represented, accounting for 27.29% of the total voting shares[90] - The second extraordinary general meeting on March 18, 2021, had 185,614,824 shares represented, which is 28.01% of the total voting shares[91] - The annual general meeting on May 20, 2021, saw 181,075,824 shares represented, making up 27.32% of the total voting shares[92] - The company approved a proposal to provide guarantees for bank loans for a subsidiary during the first extraordinary general meeting[90] - The company approved the investment in a new biopharmaceutical industrial base during the third extraordinary general meeting[93] Legal and Regulatory Matters - The company received a warning letter from the China Securities Regulatory Commission on January 7, 2021, regarding administrative regulatory measures[116] - On January 18, 2022, the company received another warning letter from the China Securities Regulatory Commission, indicating ongoing regulatory scrutiny[117] - The company has faced regulatory scrutiny from the Shanghai Stock Exchange and the China Securities Regulatory Commission due to issues related to timely disclosures and governance discrepancies[168] - The company received a total of 36 civil lawsuits related to securities false statements, with 31 cases allowing the plaintiffs to withdraw their lawsuits, 2 cases dismissed, and 3 cases upheld on appeal[163] - The company was ordered to pay a total of CNY 1,956,489.79 in economic compensation to former employees following arbitration rulings[164] Employee and Compensation - The total number of employees in the parent company and major subsidiaries is 885, with 59 in the parent company and 826 in subsidiaries[133] - The workforce consists of 518 production personnel, 61 sales personnel, 22 technical personnel, 43 financial personnel, 175 administrative personnel, and 66 workshop management personnel[133] - Total compensation for all directors, supervisors, and senior management reached RMB 5.8523 million by the end of the reporting period[107] - The company has a cash dividend policy that mandates a minimum of 20% of distributable profits to be allocated as cash dividends during periods of significant capital expenditure[136] - The company has not conducted any profit distribution for the fiscal year 2020 and 2021, focusing instead on operational and developmental needs[139] Stock and Equity Transactions - The company completed the transfer of 180,468,652 shares (27.23% of total equity) from its former largest shareholder, Jielong Group, to Lishui Zhefayilian Business Management Partnership, with the transaction fully settled during the reporting period[172] - The company received a total of RMB 558 million from the transfer of a 10% stake in Shanghai Jielong Construction Engineering Co., Ltd. to Jielong Group, with the transaction completed and registered[172] - The company has provided guarantees totaling RMB 39,340 million, which accounts for 32.43% of its net assets[176] - The company has completed the registration of a capital increase of RMB 600 million in Beijing Jielong International Trade Co., Ltd., with the ownership structure changing to 45.45% for the company and 54.55% for the actual controller[172] - The company has approved a non-public offering of 100 million shares at a price of RMB 5.11 per share, with the controlling shareholder as the subscriber[187]